AB ANALITICA x SNIBE partnership – July 22, 2024

AB ANALITICA and SNIBE are proud to announce a distribution partnership in Italy for SNIBE Molecision R8 platform, and both companies will focus on the development and commercialization of next-generation molecular tests on this platform.

AstraZeneca’s fixed-duration Calquence combo succeeds in Phase 3 blood cancer test

When given with other cancer drugs for a limited time, AstraZeneca’s Calquence hit the primary endpoint in a registrational test, which could open up a

July 30, 2024

With Ozempic, Wall Street moves on from a whole other class of medicines

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

October 11, 2023

Could reducing light exposure help you sleep better and improve your mental health during pregnancy?

Higher light exposure at night and poor sleep quality are associated with poorer mental health outcomes.

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.